Japan
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.77 B
|
Feb. 29, 2024 | USD 22.72 | 1.95% |
|
Japan |
|
2 |
USD 684.95 M
|
March 31, 2024 | USD 13.79 | -2.68% |
|
Japan |
|
3 |
USD 436.27 M
|
Feb. 29, 2024 | USD 13.61 | 0.35% |
|
Japan |
|
4 |
USD 431.52 M
|
March 31, 2024 | USD 14.64 | -0.31% |
|
Japan |
|
5 |
USD 388.67 M
|
May 31, 2024 | USD 54.75 | -0.15% |
|
Japan |
|
6 |
USD 379.52 M
|
March 31, 2024 | USD 13.29 | -0.18% |
|
Japan |
|
7 |
USD 373.51 M
|
March 31, 2024 | USD 25.64 | -1.47% |
|
Japan |
|
8 |
USD 341.60 M
|
May 31, 2024 | USD 46.43 | 6.23% |
|
Japan |
|
9 |
USD 340.78 M
|
March 31, 2024 | USD 29.09 | -1.76% |
|
Japan |
|
10 |
USD 308.24 M
|
Feb. 29, 2024 | USD 15.80 | -1.62% |
|
Japan |
|
11 |
USD 293.56 M
|
March 31, 2024 | USD 13.24 | -1.13% |
|
Japan |
|
12 |
USD 250.89 M
|
May 31, 2024 | USD 10.25 | -0.31% |
|
Japan |
|
13 |
USD 247.39 M
|
March 31, 2024 | USD 26.29 | -0.80% |
|
Japan |
|
14 |
USD 243.62 M
|
March 31, 2024 | USD 13.52 | -2.38% |
|
Japan |
|
15 |
USD 237.34 M
|
March 31, 2024 | USD 26.58 | -2.09% |
|
Japan |
|
16 |
USD 203.42 M
|
May 31, 2024 | USD 19.38 | -1.34% |
|
Japan |
|
17 |
USD 190.09 M
|
April 30, 2024 | USD 26.99 | -0.67% |
|
Japan |
|
18 |
USD 162.48 M
|
Feb. 29, 2024 | USD 29.18 | -1.15% |
|
Japan |
|
19 |
USD 160.34 M
|
May 31, 2024 | USD 17.32 | -2.71% |
|
Japan |
|
20 |
USD 153.66 M
|
Feb. 29, 2024 | USD 14.35 | 0.35% |
|
Japan |
|
21 |
USD 107.15 M
|
March 31, 2024 | USD 5.51 | -0.64% |
|
Japan |
|
22 |
USD 104.69 M
|
Feb. 29, 2024 | USD 25.09 | -0.31% |
|
Japan |
|
23 |
USD 96.83 M
|
March 31, 2024 | USD 8.86 | -0.96% |
|
Japan |
|
24 |
USD 93.89 M
|
March 31, 2024 | USD 8.93 | -1.65% |
|
Japan |
|
25 |
USD 90.12 M
|
June 30, 2024 | USD 18.89 | -4.04% |
|
Japan |
|
26 |
USD 80.35 M
|
March 31, 2024 | USD 7.73 | -0.10% |
|
Japan |
|
27 |
USD 75.95 M
|
March 31, 2024 | USD 16.01 | 0.29% |
|
Japan |
|
28 |
USD 64.73 M
|
Feb. 29, 2024 | USD 5.17 | -0.06% |
|
Japan |
|
29 |
USD 64.19 M
|
Feb. 29, 2024 | USD 13.72 | 4.49% |
|
Japan |
|
30 |
USD 54.41 M
|
Feb. 29, 2024 | USD 11.98 | -3.20% |
|
Japan |
|
31 |
USD 45.59 M
|
March 31, 2024 | USD 2.53 | -0.18% |
|
Japan |
|
32 |
USD 31.31 M
|
Sept. 30, 2024 | USD 12.19 | -2.76% |
|
Japan |
|
33 |
USD 25.14 M
|
Oct. 31, 2023 | USD 5.33 | -0.89% |
|
Japan |
|
34 |
USD 24.11 M
|
Feb. 29, 2024 | USD 7.61 | 0.07% |
|
Japan |
|
35 |
USD 23.43 M
|
Feb. 29, 2024 | USD 6.27 | -0.68% |
|
Japan |
|
36 |
USD 18.97 M
|
Sept. 30, 2024 | USD 8.80 | -0.61% |
|
Japan |
|
37 |
USD 16.67 M
|
Feb. 29, 2024 | USD 13.58 | -2.19% |
|
Japan |
|
38 |
USD 16.22 M
|
Sept. 30, 2024 | USD 2.39 | -2.51% |
|
Japan |
|
39 |
USD 15.04 M
|
May 31, 2024 | USD 5.18 | -0.43% |
|
Japan |
|
40 |
USD 14.96 M
|
March 31, 2024 | USD 10.09 | -0.56% |
|
Japan |
|
41 |
USD 13.26 M
|
May 31, 2024 | USD 3.39 | 0.76% |
|
Japan |
|
42 |
USD 12.69 M
|
March 31, 2024 | USD 4.11 | -0.49% |
|
Japan |
|
43 |
USD 11.16 M
|
Feb. 29, 2024 | USD 3.25 | -4.29% |
|
Japan |
|
44 |
USD 10.22 M
|
March 31, 2024 | USD 3.33 | -4.58% |
|
Japan |
|
45 |
USD 8.83 M
|
Feb. 29, 2024 | USD 2.66 | -2.27% |
|
Japan |
|
46 |
USD 7.19 M
|
Feb. 29, 2024 | USD 26.58 | -1.36% |
|
Japan |
|
47 |
USD 6.18 M
|
March 31, 2024 | USD 2.32 | 0.09% |
|
Japan |
|
48 |
USD 5.48 M
|
March 31, 2024 | USD 5.57 | -2.29% |
|
Japan |
|
49 |
USD 4.29 M
|
Feb. 29, 2024 | USD 3.51 | -4.32% |
|
Japan |
|
50 |
USD 3.06 M
|
March 31, 2024 | USD 11.60 | -0.24% |
|
Japan |
The Drugstores & Retail Pharmacies company in Japan with the highest EBITDA is Aeon Co., Ltd. (Tokyo Stock Exchange: 8267.T) at USD 3.77 B.
The Drugstores & Retail Pharmacies company in Japan with the lowest EBITDA is TOP CULTURE Co.,Ltd. (Tokyo Stock Exchange: 7640.T) at USD -4.91 M.
The top 10 Drugstores & Retail Pharmacies companies in Japan by EBITDA are Aeon Co., Ltd., MatsukiyoCocokara & Co., Welcia Holdings Co., Ltd., MediPal Holdings Corporation, Tsuruha Holdings Inc., Alfresa Holdings Corporation, Sundrug Co.,Ltd., COSMOS Pharmaceutical Corporation, Suzuken Co., Ltd. and Sugi Holdings Co.,Ltd..
The bottom 10 Drugstores & Retail Pharmacies companies in Japan by EBITDA are TOP CULTURE Co.,Ltd., Village Vanguard CO.,LTD., TAYA Co.,Ltd., Aigan Co.,Ltd., Plaza Holdings Co.,Ltd., CVS Bay Area Inc., Trenders, Inc., Verite Co., Ltd., Maruyoshi Center Inc. and Daiwa Co.,Ltd..